Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate efficacy and safety of co-administrated temisartan/amlodipine and rosuvastatin in subjects with dyslipidemia with hypertension.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group I | Experimental | Treatment of Telmisartan 80 mg, Amodipine 10 mg, Rosuvastatin 20 mg for 8 weeks |
|
| Group II | Active Comparator | Treatment of Telmisartan 80 mg, Amodipine 10 mg, Rosuvastatin placebo for 8 weeks |
|
| Group III | Active Comparator | Treatment of Telmisartan 80 mg, Amodipine placebo, Rosuvastatin 20 mg for 8 weeks |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Group I (Telmisartan 80 mg, Amlodipine 10 mg, Rosuvastatin 20 mg) | Drug | Twinstar(80/10 mg) and Rosuvastatin 20 mg for 8 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| change of LDL-C | baseline and 8 weeks | |
| change of msSBP | baseline and 8 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chungnam National University Hospital | Daejeon | South Korea | ||||
| Chonnam National University Hospital |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 30665829 | Derived | Hong SJ, Jeong HS, Cho JM, Chang K, Pyun WB, Ahn Y, Hyon MS, Kang WC, Lee JH, Kim HS. Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial. Clin Ther. 2019 Feb;41(2):233-248.e9. doi: 10.1016/j.clinthera.2018.12.008. Epub 2019 Jan 18. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Group II (Telmisartan 80 mg, Amodipine 10 mg, Rosuvastatin placebo) | Drug | Twinstar(80/10 mg) and Rosuvastatin placebo for 8 weeks |
|
| Group III (Telmisartan 80 mg, Amlodipine placebo, Rosuvastatin 20 mg) | Drug | Twinstar placebo, Amlodipine 10 mg and Rosuvastatin 20 mg for 8 weeks |
|
| Gwangju |
| South Korea |
| Seoul National University Bundang Hospital | Gyeonggi-do | South Korea |
| Gachon University Gil Medical Center | Incheon | South Korea |
| Inje University Haeundae Paik Hospital | Pusan | South Korea |
| Ewha Womans University Mokdong Hospital | Seoul | South Korea |
| Kangbuk Samsung Hospital | Seoul | South Korea |
| Korea University Anam Hospital | Seoul | South Korea |
| KyungHee University Hospital at Gangdong | Seoul | South Korea |
| Seoul National University Hospital | Seoul | South Korea |
| SoonChunHyang University Hospital, Seoul | Seoul | South Korea |
| The Catholic University of Korea Seoul St. Mary's Hospital | Seoul | South Korea |
| ID | Term |
|---|---|
| D000077333 | Telmisartan |
| D017311 | Amlodipine |
| D000068718 | Rosuvastatin Calcium |
| ID | Term |
|---|---|
| D001713 | Biphenyl Compounds |
| D001555 | Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D009930 | Organic Chemicals |
| D001562 | Benzimidazoles |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
| D004095 | Dihydropyridines |
| D011725 | Pyridines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D013449 | Sulfonamides |
| D000577 | Amides |
| D005464 | Fluorobenzenes |
| D006845 | Hydrocarbons, Fluorinated |
| D006846 | Hydrocarbons, Halogenated |
| D013450 | Sulfones |
| D013457 | Sulfur Compounds |
| D011743 | Pyrimidines |
Not provided
Not provided